Evolent Non Operating Income Net Other from 2010 to 2026
| EVH Stock | USD 3.25 0.07 2.11% |
Non Operating Income Net Other | First Reported 2015-06-30 | Previous Quarter 1.3 M | Current Value 733 K | Quarterly Volatility 73.6 M |
Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 62.4 M, Total Revenue of 2 B or Gross Profit of 221.6 M, as well as many indicators such as Price To Sales Ratio of 0.23, Dividend Yield of 0.0256 or PTB Ratio of 1.16. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.
Evolent | Non Operating Income Net Other | Build AI portfolio with Evolent Stock |
The Non Operating Income Net Other trend for Evolent Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Evolent Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Evolent Health's Non Operating Income Net Other Growth Pattern
Below is the plot of the Non Operating Income Net Other of Evolent Health over the last few years. It is Evolent Health's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolent Health's overall financial position and show how it may be relating to other accounts over time.
| Non Operating Income Net Other | 10 Years Trend |
|
Non Operating Income Net Other |
| Timeline |
Evolent Non Operating Income Net Other Regression Statistics
| Arithmetic Mean | 135,968,660 | |
| Coefficient Of Variation | 140.20 | |
| Mean Deviation | 176,470,122 | |
| Median | 5,995,000 | |
| Standard Deviation | 190,627,259 | |
| Sample Variance | 36338.8T | |
| Range | 424.7M | |
| R-Value | (0.82) | |
| Mean Square Error | 12784.6T | |
| R-Squared | 0.67 | |
| Significance | 0.000059 | |
| Slope | (30,903,485) | |
| Total Sum of Squares | 581420T |
Evolent Non Operating Income Net Other History
About Evolent Health Financial Statements
Investors use fundamental indicators, such as Evolent Health's Non Operating Income Net Other, to determine how well the company is positioned to perform in the future. Although Evolent Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Non Operating Income Net Other | 5.4 M | 5.1 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Evolent Health Correlation against competitors. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is there potential for Health Care Technology market expansion? Will Evolent introduce new products? Factors like these will boost the valuation of Evolent Health. Projected growth potential of Evolent fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.57) | Revenue Per Share | Quarterly Revenue Growth (0.28) | Return On Assets | Return On Equity |
Understanding Evolent Health requires distinguishing between market price and book value, where the latter reflects Evolent's accounting equity. The concept of intrinsic value - what Evolent Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Evolent Health's price substantially above or below its fundamental value.
It's important to distinguish between Evolent Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evolent Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Evolent Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.